I just walked out of our quarterly board meeting, and I’m sitting here with the most uncomfortable cognitive dissonance. On one hand, three different board members asked why we’re not moving faster on AI. On the other hand, our board-appointed finance committee chair spent 20 minutes grilling me about our current AI spend and what we have to show for it.
Welcome to the CFO’s life in 2026.
Here’s the situation: We’re a Series B fintech company, about 180 people, doing well but not crushing it. Our product team has been pitching AI initiatives for the past year. Some sound genuinely transformative. Some sound like buzzword bingo. The board sees competitors announcing AI features and gets nervous. Meanwhile, I’m getting monthly questions from our lead investor about our burn rate and path to profitability.
Last week, I read that 25% of planned AI investments are being deferred to 2027 as CFOs demand ROI first. That hit close to home because I just did exactly that - I pushed three AI projects to next year’s budget.
The Core Challenge
How do you evaluate ROI on transformative technology that hasn’t proven itself yet? Traditional finance metrics don’t quite work. If I apply our standard hurdle rate (300% ROI on discretionary tech investments), almost nothing AI-related makes the cut. But if I ignore financial discipline entirely, I’m not doing my job.
The projects I approved all had something in common: measurable outcomes within 90 days. The projects I deferred were all “trust us, this will be game-changing in 18-24 months.”
What’s Actually Working
I’ve landed on a phased approach that’s keeping both the board and our investors reasonably happy:
Phase 1 (60-90 days): Small investment (K-K), narrow scope, clear success metrics. We’re looking for 15-25% productivity improvement or cost reduction in a specific workflow. If we don’t see it, we kill the project. No sunk cost fallacy.
Phase 2 (90-180 days): If Phase 1 works, we scale it. Now we’re talking K-K. Success criteria: Can we get 3-5 teams using this? Are the productivity gains holding up?
Phase 3 (6-12 months): Full rollout and integration into product or operations. This is where we’d spend K+ and bake it into our systems.
Real Example: ML-Powered Fraud Detection
Our payment operations team proposed an ML model to detect fraudulent transactions. Traditional rules-based system was catching about 60% of fraud but generating tons of false positives.
- Phase 1 investment: K (data science contractor + 3 weeks of eng time)
- Timeline: 8 weeks
- Results: Fraud detection rate improved to 78%, false positives dropped 40%
- Measurable impact: Chargebacks reduced by K in first month
- Decision: Approved Phase 2 immediately
That’s the kind of AI project that makes it through my filter. Clear problem, measurable baseline, demonstrable improvement, calculable ROI.
The Tension I’m Wrestling With
Here’s what keeps me up at night: Are we being penny-wise and pound-foolish?
The projects that passed my ROI test are all incremental improvements. Better fraud detection. Faster document processing. Improved customer support routing. These are good projects. They save money and time.
But none of them are transformational. None of them create entirely new capabilities or business models. I look at what companies like OpenAI or Anthropic are building, and I wonder if we’re optimizing our way into irrelevance.
My VP of Engineering keeps talking about “strategic optionality” - investments that don’t show immediate ROI but position us for future opportunities. She’s probably right. But I can’t take that to our board with a straight face. “We spent K to have optionality” doesn’t fly when we’re still burning cash.
The Market Context
The macro environment isn’t helping. Global AI spending is projected to hit .5 trillion this year, but only 14% of CFOs report measurable ROI from their AI initiatives. That’s terrifying. It means 86% of us are spending money and hoping it works out.
Our investors are asking harder questions. They want monthly ROI reports. They want to see “revenue impact per dollar spent” as a line item. The days of “we’re investing in AI for the future” without concrete returns are over.
What I Need From This Community
I know we have product leaders, CTOs, engineering directors, and other finance folks here. I’m curious:
-
How are you balancing innovation budgets with accountability? What frameworks are you using?
-
What AI investments have you made that didn’t show immediate ROI but proved valuable later? How did you justify them?
-
For the engineering and product folks: What do you wish your CFO understood about AI investment that we’re probably missing?
-
For other finance leaders: How are you measuring “strategic value” vs. direct ROI? Or are you just not funding the strategic stuff right now?
I want to be the CFO who enables innovation, not the one who kills it. But I also need to be the CFO who can explain our spend to the board and our investors. Right now, those two things feel in tension.
What am I missing?